Post-mortem toxico-kinetics of trazodone

https://doi.org/10.1016/0379-0738(92)90180-5Get rights and content

Abstract

Trazodone is a structurally unique bicyclic anti-depressant, said to be significantly less toxic than other anti-depressants following an acute overdose. We studied the tissue distribution and post-mortem redistribution of trazodone in two fatalities, one of which allowed comparison with trimipramine, a typical tricyclic anti-depressant. Case 1, a 53-year-old female weighing 72 kg, had femoral vein concentrations of trimipramine 5.5 μg/ml, trazodone 14.4 μg/ml and alcohol 107 mg%. Case 2, a 48-year-old female of 70 kg, had a femoral vein trazodone of 15.5 μg/ml and alcohol 34 mg%, with no other drugs detected. For case 1 and case 2 respectively, trazodone tissue concentrations were: skeletal muscle 7.3 and 9.0 μg/g; left and right lungs 13.3, 12.9 and 35.3, 40.1; myocardium, 30.9 and 28.9; kidneys 34.7 and 39.6; liver 73.7 and 82.4; fat 18.5 and 16.5; brain 48.6 and 20.9. For case 1 and 2, respectively, blood trazodone concentrations in 10 initial autopsy samples ranged from 13.7–17.3 and 14.4–16.9 μg/ml. Twenty-four and forty-eight hours later the respective ranges were 12.8–18.0 and 12.4–19.9 for case 1, 12.5–20.1 and 12.7–27.0 for case 2. By contrast, for trimipramine, blood concentrations at 0 time, 24 h and 48 hours ranged from 5.5–11.4, 5.2–14.3, and 4.2–18.2, respectively. We conclude that trazodone shows little preferential concentration in solid organs and consequently has relatively stable post-mortem blood concentrations with little drug redistribution artefact. Both the clinical pharmacokinetics and post-mortem toxicokinetics of trazodone differ significantly from the tricyclic anti-depressants.

References (16)

  • A.J. Bayer et al.

    Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly

    Br. J. Clin, Pharmacol.

    (1983)
  • E. Hassan et al.

    Toxicity and elimination of trazodone after overdose

    Clin. Pharm.

    (1985)
  • R.N. Brogden et al.

    Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety

    Drugs

    (1981)
  • G.R. Jones et al.

    Site-dependence of drug concentrations in post-mortem blood — a case study

    J. Anal. Toxicol.

    (1987)
  • K. Simpson

    A Doctors Guide to Court

  • D.R. Abernethy et al.

    Trimipramine kinetics and absolute bioavailability: use of gas-liquid chromatography with nitrogen-phosphorus detection

    Clin. Pharm. Ther.

    (1984)
  • B. Catanese et al.

    Investigations on the absorption and distribution of trazodone or AF 1161 in rats, dogs and humans

    Boll. Chim. Farm

    (1970)
There are more references available in the full text version of this article.

Cited by (35)

  • Postmortem distribution of trazodone concentrations

    2015, Forensic Science International
    Citation Excerpt :

    Postmortem concentrations, on the other hand, have been described after an overdose with 2–4 g trazodone at a blood concentration of 15 mg/L, and liver 57 mg/kg [13]. Two other cases were found to have concentrations of 14.4 and 15.5 mg/L in blood, and 73.7 and 82.4 mg/kg in liver [14]. Three subjects with blood concentrations of 9.0, 24.3 and 32.9 mg/L were determined as deaths attributed primarily to trazodone [15].

  • Evaluation of postmortem redistribution phenomena for commonly encountered drugs

    2012, Forensic Science International
    Citation Excerpt :

    For remaining drugs, the interpretation of PMR was not performed because of statistical limitation (n = 1). Studies on amitriptyline [4,18,28,31,33,34,54,55], carbamazepine [28,30,31,36,37], tramadol [22,46,56–59] and trazodone [47–49,60–63] related deaths and PMR have frequently been reported. Propofol related deaths [64–69] have frequently been reported, but studies on PMR of propofol have not been reported.

View all citing articles on Scopus
View full text